Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind randomized trial of topical nano-liposomal paromomycin for cutaneous leishmaniasis (L. major)
IRCT201108301475N6Phase 3Completed
- Sponsor
- Center for Research and Training in Skin Diseases and Leprosy
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of paromomycin in cutaneous leishmaniasis (CL), sponsored by Center for Research and Training in Skin Diseases and Leprosy. Started Sep 2011; status: completed.
02
Drugs
paromomycin
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT201108301475N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108301475N6.